Strensiq
Payments companies reported to CMS as associated with Strensiq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Strensiq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Strensiq
These are the largest totals companies reported as associated with Strensiq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eric Rush | Kansas City, MO | Clinical Genetics (M.D.) | $161,962.95 |
| Steven Petak | Houston, TX | Endocrinology, Diabetes & Metabolism | $136,443.06 |
| Kathryn Dahir | Nashville, TN | Endocrinology, Diabetes & Metabolism | $61,844.07 |
| Jacqueline Kernaghan | Springfield, PA | Medical | $46,560.07 |
| Daniel Malone | Beaver Dam, WI | Rheumatology | $45,885.98 |
| Leila Chaychi | San Carlos, CA | Endocrinology, Diabetes & Metabolism | $32,435.88 |
| Gnanagurdasan Prakasam | Sacramento, CA | Pediatric Endocrinology | $31,154.05 |
| Dhiman Basu | Colleyville, TX | Rheumatology | $31,093.34 |
| Rachel Lombardo | Phoenix, AZ | Clinical Genetics (M.D.) | $26,265.58 |
| Eduardo Luna | Edinburg, TX | Endocrinology, Diabetes & Metabolism | $26,182.54 |
Prescribed Strensiq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.